Activation of dendritic cells via TLR7 reduces Foxp3 expression and suppressive function in induced Tregs

European Journal of Immunology

Volumn 41, Issue 5, 2011, Pages 1334-1343

  Hackl, Daniela ^a   Loschko, Jakob ^a   Sparwasser, Tim ^b   Reindl, Wolfgang ^a   Krug, Anne B ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b INSTITUTE OF INFECTION IMMUNOLOGY   (Germany)

Author keywords

DCs; Systemic lupus erythematosus; TLR7; Treg cells

Indexed keywords

INTERLEUKIN 6; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 9; TRANSCRIPTION FACTOR FOXP3;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL ACTIVATION; CYTOKINE PRODUCTION; DENDRITIC CELL; DOWN REGULATION; GENETIC TRANSFECTION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REGULATORY T LYMPHOCYTE;

ANIMALS; CELL DIFFERENTIATION; COCULTURE TECHNIQUES; DENDRITIC CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; FORKHEAD TRANSCRIPTION FACTORS; IMMUNE TOLERANCE; INTERLEUKIN-6; LIGANDS; LYMPHOCYTE ACTIVATION; MEMBRANE GLYCOPROTEINS; MICE; MICE, CONGENIC; MICE, INBRED BALB C; MICE, INBRED C57BL; RNA; T-LYMPHOCYTES, REGULATORY; TOLL-LIKE RECEPTOR 7; TOLL-LIKE RECEPTOR 9; TRANSFORMING GROWTH FACTOR BETA;

EID: 79955142513     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201041014     Document Type: Article

References (36)

1. Barrat, F. J., Meeker, T., Gregorio, J., Chan, J. H., Uematsu, S., Akira, S., Chang, B. et al., Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus. J. Exp. Med. 2005. 202: 1131-1139.
2. Diebold, S. S., Kaisho, T., Hemmi, H., Akira, S. and Reis e Sousa, C., Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 2004. 303: 1529-1531.
3. Heil, F., Hemmi, H., Hochrein, H., Ampenberger, F., Kirschning, C., Akira, S., Lipford, G. et al., Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science 2004. 303: 1526-1529.
4. Lau, C. M., Broughton, C., Tabor, A. S., Akira, S., Flavell, R. A., Mamula, M. J., Christensen, S. R. et al., RNA-associated autoantigens activate B cells by combined B cell antigen receptor/Toll-like receptor 7 engagement. J. Exp. Med. 2005. 202: 1171-1177.
5. Savarese, E., Chae, O. W., Trowitzsch, S., Weber, G., Kastner, B., Akira, S., Wagner, H. et al., U1 small nuclear ribonucleoprotein immune complexes induce type I interferon in plasmacytoid dendritic cells through TLR7. Blood 2006. 107: 3229-3234.
6. Vollmer, J., Tluk, S., Schmitz, C., Hamm, S., Jurk, M., Forsbach, A., Akira, S. et al., Immune stimulation mediated by autoantigen binding sites within small nuclear RNAs involves Toll-like receptors 7 and 8. J. Exp. Med. 2005. 202: 1575-1585.
7. Koyama, S., Ishii, K. J., Kumar, H., Tanimoto, T., Coban, C., Uematsu, S., Kawai, T. and Akira, S., Differential role of TLR- and RLR-signaling in the immune responses to influenza A virus infection and vaccination. J. Immunol. 2007. 179: 4711-4720.
8. Anders, H. J., Krug, A. and Pawar, R. D., Molecular mimicry in innate immunity? The viral RNA recognition receptor TLR7 accelerates murine lupus. Eur. J. Immunol. 2008. 38: 1795-1799.
9. Berland, R., Fernandez, L., Kari, E., Han, J. H., Lomakin, I., Akira, S., Wortis, H. H. et al., Toll-like receptor 7-dependent loss of B cell tolerance in pathogenic autoantibody knockin mice. Immunity 2006. 25: 429-440.
10. Christensen, S. R., Shupe, J., Nickerson, K., Kashgarian, M., Flavell, R. A. and Shlomchik, M. J., Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus. Immunity 2006. 25: 417-428.
11. Deane, J. A., Pisitkun, P., Barrett, R. S., Feigenbaum, L., Town, T., Ward, J. M., Flavell, R. A. and Bolland, S., Control of toll-like receptor 7 expression is essential to restrict autoimmunity and dendritic cell proliferation. Immunity 2007. 27: 801-810.
12. Fairhurst, A. M., Hwang, S. H., Wang, A., Tian, X. H., Boudreaux, C., Zhou, X. J., Casco, J. et al., Yaa autoimmune phenotypes are conferred by overexpression of TLR7. Eur. J. Immunol. 2008. 38: 1971-1978.
13. Savarese, E., Steinberg, C., Pawar, R. D., Reindl, W., Akira, S., Anders, H. J. and Krug, A., Requirement of Toll-like receptor 7 for pristane-induced production of autoantibodies and development of murine lupus nephritis. Arthritis Rheum. 2008. 58: 1107-1115.
14. Pasare, C. and Medzhitov, R., Toll-dependent control mechanisms of CD4 T cell activation. Immunity 2004. 21: 733-741.
15. La Cava, A., T-regulatory cells in systemic lupus erythematosus. Lupus 2008. 17: 421-425.
16. Miyara, M., Amoura, Z., Parizot, C., Badoual, C., Dorgham, K., Trad, S., Nochy, D. et al., Global natural regulatory T cell depletion in active systemic lupus erythematosus. J. Immunol. 2005. 175: 8392-8400.
17. Valencia, X., Yarboro, C., Illei, G. and Lipsky, P. E., Deficient CD4+CD25high T regulatory cell function in patients with active systemic lupus erythematosus. J. Immunol. 2007. 178: 2579-2588.
18. Wan, S., Xia, C. and Morel, L., IL-6 produced by dendritic cells from lupus-prone mice inhibits CD4+CD25+ T cell regulatory functions. J. Immunol. 2007. 178: 271-279.
19. Anz, D., Koelzer, V. H., Moder, S., Thaler, R., Schwerd, T., Lahl, K., Sparwasser, T. et al., Immunostimulatory RNA blocks suppression by regulatory T cells. J. Immunol. 2010. 184: 939-946.
20. Forward, N. A., Furlong, S. J., Yang, Y., Lin, T. J. and Hoskin, D. W., Signaling through TLR7 enhances the immunosuppressive activity of murine CD4+CD25+ T regulatory cells. J. Leukoc. Biol. 2010. 87: 117-125.
21. Caramalho, I., Lopes-Carvalho, T., Ostler, D., Zelenay, S., Haury, M. and Demengeot, J., Regulatory T cells selectively express toll-like receptors and are activated by lipopolysaccharide. J. Exp. Med. 2003. 197: 403-411.
22. Wei, J., Duramad, O., Perng, O. A., Reiner, S. L., Liu, Y. J. and Qin, F. X., Antagonistic nature of T helper 1/2 developmental programs in opposing peripheral induction of Foxp3+ regulatory T cells. Proc. Natl. Acad. Sci. USA 2007. 104: 18169-18174.
23. Wan, Y. Y. and Flavell, R. A., Regulatory T-cell functions are subverted and converted owing to attenuated Foxp3 expression. Nature 2007. 445: 766-770.
24. Huehn, J., Siegmund, K., Lehmann, J. C., Siewert, C., Haubold, U., Feuerer, M., Debes, G. F. et al., Developmental stage, phenotype, and migration distinguish naive- and effector/memory-like CD4+ regulatory T cells. J. Exp. Med. 2004. 199: 303-313.
25. Zhao, D., Zhang, C., Yi, T., Lin, C. L., Todorov, I., Kandeel, F., Forman, S. and Zeng, D., In vivo-activated CD103+CD4+ regulatory T cells ameliorate ongoing chronic graft-versus-host disease. Blood 2008. 112: 2129-2138.
26. Zhou, X., Bailey-Bucktrout, S. L., Jeker, L. T., Penaranda, C., Martinez-Llordella, M., Ashby, M., Nakayama, M. et al., Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo. Nat. Immunol. 2009. 10: 1000-1007.
27. Hall, J. A., Bouladoux, N., Sun, C. M., Wohlfert, E. A., Blank, R. B., Zhu, Q., Grigg, M. E. et al., Commensal DNA limits regulatory T cell conversion and is a natural adjuvant of intestinal immune responses. Immunity 2008. 29: 637-649.
28. Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M., Weiner, H. L. and Kuchroo, V. K., Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006. 441: 235-238.
29. Korn, T., Mitsdoerffer, M., Croxford, A. L., Awasthi, A., Dardalhon, V. A., Galileos, G., Vollmar, P. et al., IL-6 controls Th17 immunity in vivo by inhibiting the conversion of conventional T cells into Foxp3+ regulatory T cells. Proc. Natl. Acad. Sci. USA 2008. 105: 18460-18465.
30. Lochner, M., Peduto, L., Cherrier, M., Sawa, S., Langa, F., Varona, R., Riethmacher, D. et al., In vivo equilibrium of proinflammatory IL-17+ and regulatory IL-10+ Foxp3+ RORgamma t+ T cells. J. Exp. Med. 2008. 205: 1381-1393.
31. Yang, X. O., Nurieva, R., Martinez, G. J., Kang, H. S., Chung, Y., Pappu, B. P., Shah, B. et al., Molecular antagonism and plasticity of regulatory and inflammatory T cell programs. Immunity 2008. 29: 44-56.
32. Lal, G., Zhang, N., van der Touw, W., Ding, Y., Ju, W., Bottinger, E. P., Reid, S. P. et al., Epigenetic regulation of Foxp3 expression in regulatory T cells by DNA methylation. J. Immunol. 2009. 182: 259-273.
33. Samanta, A., Li, B., Song, X., Bembas, K., Zhang, G., Katsumata, M., Saouaf, S. J. et al., TGF-beta and IL-6 signals modulate chromatin binding and promoter occupancy by acetylated FOXP3. Proc. Natl. Acad. Sci. USA 2008. 105: 14023-14027.
34. Pasare, C. and Medzhitov, R., Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells. Science 2003. 299: 1033-1036.
35. Hemmi, H., Kaisho, T., Takeuchi, O., Sato, S., Sanjo, H., Hoshino, K., Horiuchi, T. et al., Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway. Nat. Immunol. 2002. 3: 196-200.
36. Lahl, K., Loddenkemper, C., Drouin, C., Freyer, J., Arnason, J., Eberl, G., Hamann, A. et al., Selective depletion of Foxp3+ regulatory T cells induces a scurfy-like disease. J. Exp. Med. 2007. 204: 57-63.